What was the high in the last 52 weeks of accolade stock?

The high in the last 52 weeks of Accolade stock was 17.01. According to the current price, Accolade is 76.86% away from the 52-week high. What are analysts forecasts for Accolade stock?

Is accolade stock a good buy?

Accolade stock has received a consensus rating of buy. The average rating score is and is based on 35 buy ratings, 17 hold ratings, and 1 sell ratings. What was the 52-week low for Accolade stock? The low in the last 52 weeks of Accolade stock was 5.24. According to the current price, Accolade is 249.43% away from the 52-week low.

What is the target price for Accolade?

The 53 analysts offering price forecasts for Accolade have a median target of 23.25, with a high estimate of 70.00 and a low estimate of 6.00. The median estimate represents a 56.20 difference from the last price of 13.07.

Which ETFs hold accolade (ACCD) stock?

ETFs with the largest weight of Accolade (NASDAQ:ACCD) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), SPDR S&P Health Care Services ETF (XHS), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Micro-Cap ETF (IWC). iShares U.S. Healthcare Providers ETF (IHF).